Literature DB >> 20506227

Permanently blocked stem cells derived from breast cancer cell lines.

Gangadharan B Sajithlal1, Kristi Rothermund, Fang Zhang, David J Dabbs, Jean J Latimer, Stephen G Grant, Edward V Prochownik.   

Abstract

Cancer stem cells (CSCs) are thought to be resistant to standard chemotherapeutic drugs and the inimical conditions of the tumor microenvironment. Obtaining CSCs in sufficient quantities and maintaining their undifferentiated state have been major hurdles to their further characterization and to the identification of new pharmaceuticals that preferentially target these cells. We describe here the tagging of CSC-like populations from four human breast cancer cell lines with green fluorescent protein (GFP) under the control of the Oct3/4 stem cell-specific promoter. As expected, GFP was expressed by the CSC-enriched populations. However, an unanticipated result was that these cells remained blocked in a CSC-like state and tended to be resistant to chemotherapeutic drugs as well as acidotic and hypoxic conditions. These CSC-like cells possessed several other in vitro attributes of CSCs and were able to reproducibly generate tumors in immunocompromised mice from as few as 100 cells. Moreover, the tumors derived from these cells were comprised almost exclusively of pure CSCs. The ability of the Oct3/4 promoter to block CSC differentiation underscores its potential general utility for obtaining highly purified CSC populations, although the mechanism by which it does so remains undefined and subject to further study. Nonetheless, such stable cell lines should be extremely valuable tools for studying basic questions pertaining to CSC biology and for the initial identification of novel CSC-specific chemotherapeutic agents, which can then be verified in primary CSCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20506227      PMCID: PMC4744791          DOI: 10.1002/stem.424

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  59 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 3.  Cancer stem cells: lessons from leukemia.

Authors:  Jean C Y Wang; John E Dick
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

Review 4.  Cancer stem cells: how can we target them?

Authors:  Ivan Ischenko; Hendrik Seeliger; Moshe Schaffer; Karl-Walter Jauch; Christiane J Bruns
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.

Authors:  Marleen Kok; Rutger H Koornstra; Tania C Margarido; Renske Fles; Nicola J Armstrong; Sabine C Linn; Laura J Van't Veer; Britta Weigelt
Journal:  J Pathol       Date:  2009-07       Impact factor: 7.996

Review 6.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

Authors:  Madhuri Kakarala; Max S Wicha
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

7.  Embryonic stem cell markers expression in cancers.

Authors:  Matthieu Schoenhals; Alboukadel Kassambara; John De Vos; Dirk Hose; Jérôme Moreaux; Bernard Klein
Journal:  Biochem Biophys Res Commun       Date:  2009-03-04       Impact factor: 3.575

8.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

9.  Leukemia stem cells in a genetically defined murine model of blast-crisis CML.

Authors:  Sarah J Neering; Timothy Bushnell; Selcuk Sozer; John Ashton; Randall M Rossi; Pin-Yi Wang; Deborah R Bell; David Heinrich; Andrea Bottaro; Craig T Jordan
Journal:  Blood       Date:  2007-06-29       Impact factor: 22.113

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

View more
  17 in total

1.  Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.

Authors:  Jiyeon Yun; Sang-Hyun Song; Hwang-Phill Kim; Sae-Won Han; Eugene C Yi; Tae-You Kim
Journal:  EMBO Rep       Date:  2016-07-27       Impact factor: 8.807

Review 2.  Breast cancer stem cells.

Authors:  Marco A Velasco-Velázquez; Nora Homsi; Marisol De La Fuente; Richard G Pestell
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

3.  Molecular characteristics of cancer stem-like cells derived from human breast cancer cells.

Authors:  Young Dong Yoo; Dong Hoon Han; Jun Min Jang; Adriana Zakrzewska; Seog-Young Kim; Cheol Yong Choi; Yong Jun Lee; Yong Tae Kwon
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

4.  Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.

Authors:  Seog-Young Kim; Jin Wook Kang; Xinxin Song; Bo Kyoung Kim; Young Dong Yoo; Yong Tae Kwon; Yong J Lee
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

Review 5.  Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway?

Authors:  Hassan Fazilaty; Mossa Gardaneh; Tayyeb Bahrami; Arash Salmaninejad; Babak Behnam
Journal:  Tumour Biol       Date:  2013-05-19

6.  Tumor-Initiating Cells: Emerging Biophysical Methods of Isolation.

Authors:  Efraín A Cermeño; Andrés J García
Journal:  Curr Stem Cell Rep       Date:  2016-02-09

7.  Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.

Authors:  Kaiji Hu; Jennifer H Law; Abbas Fotovati; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2012-02-06       Impact factor: 6.466

8.  Bouvardin is a Radiation Modulator with a Novel Mechanism of Action.

Authors:  Stefanie A Stickel; Nathan P Gomes; Barbara Frederick; David Raben; Tin Tin Su
Journal:  Radiat Res       Date:  2015-09-28       Impact factor: 2.841

9.  Phenotypic screening reveals topoisomerase I as a breast cancer stem cell therapeutic target.

Authors:  Fang Zhang; Kristi Rothermund; Sajithlal B Gangadharan; Yves Pommier; Edward V Prochownik; John S Lazo
Journal:  Oncotarget       Date:  2012-09

10.  Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM.

Authors:  Seog-Young Kim; Juong G Rhee; Xinxin Song; Edward V Prochownik; Douglas R Spitz; Yong J Lee
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.